393 related articles for article (PubMed ID: 2679373)
1. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
[TBL] [Abstract][Full Text] [Related]
2. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli.
Cohen SP; McMurry LM; Levy SB
J Bacteriol; 1988 Dec; 170(12):5416-22. PubMed ID: 2848006
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
Hooper DC; Wolfson JS; Souza KS; Ng EY; McHugh GL; Swartz MN
Antimicrob Agents Chemother; 1989 Mar; 33(3):283-90. PubMed ID: 2658782
[TBL] [Abstract][Full Text] [Related]
4. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli.
Mortimer PG; Piddock LJ
J Antimicrob Chemother; 1993 Aug; 32(2):195-213. PubMed ID: 8226422
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
Hirai K; Aoyama H; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Aug; 30(2):248-53. PubMed ID: 3532944
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
[TBL] [Abstract][Full Text] [Related]
7. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.
Hächler H; Cohen SP; Levy SB
J Bacteriol; 1991 Sep; 173(17):5532-8. PubMed ID: 1715857
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
Chamberland S; Bayer AS; Schollaardt T; Wong SA; Bryan LE
Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
[TBL] [Abstract][Full Text] [Related]
10. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
Hooper DC; Wolfson JS; Souza KS; Tung C; McHugh GL; Swartz MN
Antimicrob Agents Chemother; 1986 Apr; 29(4):639-44. PubMed ID: 3010850
[TBL] [Abstract][Full Text] [Related]
11. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.
Li XZ; Livermore DM; Nikaido H
Antimicrob Agents Chemother; 1994 Aug; 38(8):1732-41. PubMed ID: 7986003
[TBL] [Abstract][Full Text] [Related]
12. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway.
Cohen SP; Levy SB; Foulds J; Rosner JL
J Bacteriol; 1993 Dec; 175(24):7856-62. PubMed ID: 7504664
[TBL] [Abstract][Full Text] [Related]
13. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones.
Goldman JD; White DG; Levy SB
Antimicrob Agents Chemother; 1996 May; 40(5):1266-9. PubMed ID: 8723480
[TBL] [Abstract][Full Text] [Related]
14. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.
Chow RT; Dougherty TJ; Fraimow HS; Bellin EY; Miller MH
Antimicrob Agents Chemother; 1988 Aug; 32(8):1113-8. PubMed ID: 3056251
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
Xia P; Feng P; Zhong L; Lu X; Lei B
Chin Med J (Engl); 2002 Jan; 115(1):31-5. PubMed ID: 11930654
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli.
George AM; Hall RM; Stokes HW
Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1909-1920. PubMed ID: 7551053
[TBL] [Abstract][Full Text] [Related]
17. Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
Cohen SP; Hooper DC; Wolfson JS; Souza KS; McMurry LM; Levy SB
Antimicrob Agents Chemother; 1988 Aug; 32(8):1187-91. PubMed ID: 3056253
[TBL] [Abstract][Full Text] [Related]
18. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains.
Tavío MM; Vila J; Perilli M; Casañas LT; Maciá L; Amicosante G; Jiménez de Anta MT
J Med Microbiol; 2004 Nov; 53(Pt 11):1119-1122. PubMed ID: 15496390
[TBL] [Abstract][Full Text] [Related]
19. Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.
Zhanel GG; Karlowsky JA; Saunders MH; Davidson RJ; Hoban DJ; Hancock RE; McLean I; Nicolle LE
Antimicrob Agents Chemother; 1995 Feb; 39(2):489-95. PubMed ID: 7726519
[TBL] [Abstract][Full Text] [Related]
20. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci.
Moken MC; McMurry LM; Levy SB
Antimicrob Agents Chemother; 1997 Dec; 41(12):2770-2. PubMed ID: 9420057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
